CG Oncology: Upgraded, Rising, But Should We Still Be Optimistic?

Core Insights - The sentiment towards CG Oncology, Inc. has shifted from "Hold" to "Buy" due to anticipated key catalysts in 2025 [1] Company Analysis - CG Oncology, Inc. is positioned for potential growth based on upcoming developments expected in 2025 [1] Industry Context - The analysis emphasizes the importance of understanding the science behind biotech investments, highlighting the need for thorough due diligence in this sector [1]